Fellowship Type Matters for HP Cancer Surgery Outcomes
Surgeons trained in dedicated hepato-pancreato-biliary fellowships see better patient outcomes after HP cancer surgeries.
Newsletter
HPB & Spleen
Every new paper in this field, in your inbox.
Impact of Hospital Volume on Necrotizing Pancreatitis Outcomes
High-volume hospitals improve survival and reduce costs for necrotizing pancreatitis patients.
Predictive Organoid Profiles Improve Outcomes in Pancreatic Cancer
Patient-derived organoid testing shows promise for tailoring therapy in pancreatic ductal adenocarcinoma.
New Algorithm Accurately Classifies Hepatobiliary Complications
An innovative algorithm from routine data can effectively classify 30-day postoperative complications in hepatobiliary surgery, helping surgeons better understand patient outcomes.
New Technique Enhances Robotic Distal Pancreatic Tumor Surgery
A novel vascular occlusion method improves surgical outcomes in robotic enucleation of distal pancreatic tumors, crucial for better visualization and safety.
Colorectal cancer liver metastases: new strategies for unresectable cases
Surgeons need to adapt to evolving treatments for unresectable colorectal liver metastases (uCRLM) that significantly impact outcomes.
Higher Pancreatic Cancer Risk in IPMN Surveillance Patients
Surveillance for intraductal papillary mucinous neoplasms (IPMNs) reveals a tenfold increased risk of pancreatic adenocarcinoma compared to the general population.
Managing Median Arcuate Ligament in Pancreaticoduodenectomy
Median arcuate ligament (MAL) can significantly affect outcomes in pancreaticoduodenectomy (PD) patients.
Increased Mortality in Robotic Pancreatic Surgery
Surgeons need to be aware that robotic pancreaticoduodenectomy (RPD) initially carries higher mortality risks compared to open procedures.
Perioperative CA19-9 Tracking Improves Prognosis in Pancreatic Cancer
Tracking CA19-9 levels after pancreatic cancer resection can better guide surgical prognostication and patient outcomes.